{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:04:29Z","timestamp":1793639069742,"version":"4.5.1"},"reference-count":127,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U22A20328"],"award-info":[{"award-number":["U22A20328"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["23ZR1475000"],"award-info":[{"award-number":["23ZR1475000"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["20430711800"],"award-info":[{"award-number":["20430711800"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jconrel.2026.114949","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T23:31:42Z","timestamp":1776814302000},"page":"114949","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Tumor microenvironment activatable immunomodulator for cancer immunotherapy"],"prefix":"10.1016","volume":"395","author":[{"given":"Weiqi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingxing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijiao","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjiao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2026.114949_bb0005","article-title":"Neoadjuvant immunochemotherapy plus thymalfasin in locally advanced gastric cancer: a prospective clinical trial","volume":"24","author":"Hao","year":"2026","journal-title":"BMC Biomed. Eng."},{"key":"10.1016\/j.jconrel.2026.114949_bb0010","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.70339","article-title":"Review of patient-reported outcomes in EMPOWER-Lung 1 in patients with advanced non-small cell lung cancer treated with cemiplimab versus chemotherapy","volume":"132","author":"Gandara","year":"2026","journal-title":"Cancer"},{"key":"10.1016\/j.jconrel.2026.114949_bb0015","article-title":"A single-arm phase ib study of personalized peptide-pulsed dendritic cell-based multiple target cytotoxic t lymphocyte immunotherapy in combination with toripalimab as second-line therapy in advanced non-small-cell lung cancer","volume":"75","author":"Weihong","year":"2026","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.jconrel.2026.114949_bb0020","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41577-019-0218-4","article-title":"Tumour-intrinsic resistance to immune checkpoint blockade","volume":"20","author":"Kalbasi","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2026.114949_bb0025","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1080\/13543776.2025.2462849","article-title":"Small molecules targeting immune checkpoint proteins for cancer immunotherapy: a patent and literature review (2020-2024)","volume":"35","author":"Qiaohong","year":"2025","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.jconrel.2026.114949_bb0030","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41408-021-00459-7","article-title":"CAR-T cell therapy: current limitations and potential strategies","volume":"11","author":"Sterner","year":"2021","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.jconrel.2026.114949_bb0035","article-title":"MRNA-based CAR t cell engineering: unmodified mRNA enables high CAR expression without innate immune activation in t cells","volume":"37","author":"Nourhan","year":"2026","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2026.114949_bb0040","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jconrel.2019.12.047","article-title":"Current challenges and emerging opportunities of CAR-T cell therapies","volume":"319","author":"Abreu","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114949_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120709","article-title":"Nanobiomaterial-based vaccination immunotherapy of cancer","volume":"270","author":"Chen","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2026.114949_bb0050","first-page":"1351217","article-title":"Personalized cancer vaccine design using AI-powered technologies","volume":"15","author":"Anant","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.114949_bb0055","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.blre.2015.10.001","article-title":"Vaccinations in patients with hematological malignancies","volume":"30","author":"Tsigrelis","year":"2015","journal-title":"Blood Rev."},{"key":"10.1016\/j.jconrel.2026.114949_bb0060","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1056\/NEJMoa1406498","article-title":"Genetic basis for clinical response to CTLA-4 blockade in melanoma","volume":"371","author":"Snyder","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2026.114949_bb0065","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S1470-2045(17)30422-9","article-title":"Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study","volume":"18","author":"Overman","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jconrel.2026.114949_bb0070","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/S0140-6736(21)02098-5","article-title":"Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB\u2013IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial","volume":"398","author":"Felip","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2026.114949_bb0075","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13045-019-0804-8","article-title":"Tumor-intrinsic signaling pathways: key roles in the regulation of the immunosuppressive tumor microenvironment","volume":"12","author":"Yang","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jconrel.2026.114949_bb0080","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1038\/s41418-023-01149-6","article-title":"Telomerase deficiency and dysfunctional telomeres in the lung tumor microenvironment impair tumor progression in NSCLC mouse models and patient-derived xenografts","volume":"30","author":"Sergio","year":"2023","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jconrel.2026.114949_bb0085","first-page":"4118","article-title":"Mitochondrial energy metabolism correlates with an immunosuppressive tumor microenvironment and poor prognosis in esophageal squamous cell carcinoma, computational and structural","volume":"21","author":"Zewei","year":"2023","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.jconrel.2026.114949_bb0090","article-title":"Autophagy-related gene expression classification defines three molecular subtypes with distinct clinical and microenvironment cell infiltration characteristics in colon cancer","volume":"87","author":"Shajun","year":"2020","journal-title":"Int. J. Immunopharmacol."},{"key":"10.1016\/j.jconrel.2026.114949_bb0095","article-title":"Immune infiltration, effector t-cell enrichment, and functional context for prediction of pathologic complete response to neoadjuvant chemotherapy in breast cancer","volume":"27","author":"Ana","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2026.114949_bb0100","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1002\/1878-0261.13268","article-title":"Cellular senescence and the tumour microenvironment","volume":"16","author":"Takasugi","year":"2022","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.jconrel.2026.114949_bb0105","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41568-021-00366-w","article-title":"Cancer stem cell\u2013immune cell crosstalk in tumour progression","volume":"21","author":"Bayik","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2026.114949_bb0110","article-title":"An extensive overview of the role of lncRNAs generated from immune cells in the etiology of cancer","volume":"133","author":"Hong","year":"2024","journal-title":"Int. J. Immunopharmacol."},{"key":"10.1016\/j.jconrel.2026.114949_bb0115","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13045-023-01478-6","article-title":"Metabolism, metabolites, and macrophages in cancer","volume":"16","author":"Li","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jconrel.2026.114949_bb0120","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1097\/HEP.0000000000000237","article-title":"Mechanisms of drug resistance in HCC","volume":"79","author":"Ladd","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.jconrel.2026.114949_bb0125","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","article-title":"Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.114949_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112274","article-title":"Hypoxia-activated nanomedicines for effective cancer therapy","volume":"195","author":"Zhou","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jconrel.2026.114949_bb0135","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41586-024-07822-1","article-title":"The periosteum provides a stromal defence against cancer invasion into the bone","volume":"634","author":"Nakamura","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.114949_bb0140","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s12943-024-02137-1","article-title":"Prostate cancer microenvironment: multidimensional regulation of immune cells, vascular system, stromal cells, and microbiota","volume":"23","author":"Chen","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2026.114949_bb0145","article-title":"The role of CD101 and tim3 in the immune microenvironment of gastric cancer and their potential as prognostic biomarkers","volume":"146","author":"Zhouyang","year":"2024","journal-title":"Int. J. Immunopharmacol."},{"key":"10.1016\/j.jconrel.2026.114949_bb0150","doi-asserted-by":"crossref","first-page":"1517887","DOI":"10.3389\/fphar.2025.1517887","article-title":"TUBA1B as a novel prognostic biomarker correlated with immunosuppressive tumor microenvironment and immunotherapy response","volume":"16","author":"Juntao","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2026.114949_bb0155","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.immuni.2023.09.011","article-title":"The cancer-immunity cycle: indication, genotype, and immunotype","volume":"56","author":"Mellman","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2026.114949_bb0160","first-page":"86","article-title":"A review of cancer immunotherapy toxicity","volume":"70","author":"Kennedy","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jconrel.2026.114949_bb0165","article-title":"A pH-responsive charge-reversal drug delivery system with tumor-specific drug release and ROS generation for cancer therapy","volume":"15","author":"Chen","year":"2020","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2026.114949_bb0170","doi-asserted-by":"crossref","first-page":"2464189","DOI":"10.1080\/10717544.2025.2464189","article-title":"Synergistic effect of pH-sensitive PEGylated RG3-chitosan prodrug nanoparticles encapsulated celastrol on pancreatic cancer","volume":"32","author":"Zheng","year":"2025","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2026.114949_bb0175","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1080\/10717544.2022.2110998","article-title":"Prostate-specific membrane antigen targeted, glutathione-sensitive nanoparticles loaded with docetaxel and enzalutamide for the delivery to prostate cancer","volume":"29","author":"Yang","year":"2022","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2026.114949_bb0180","doi-asserted-by":"crossref","first-page":"5443","DOI":"10.1021\/acs.analchem.5c06861","article-title":"Endogenous-activatable nanotheranostic platform for multimodal bioimaging-guided photodynamic and gas synergistic cancer therapy","volume":"98","author":"Yuhang","year":"2026","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jconrel.2026.114949_bb0185","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1080\/10717544.2022.2039803","article-title":"Combination of chemotherapy and immune checkpoint therapy by the immunoconjugates-based nanocomplexes synergistically improves therapeutic efficacy in SCLC","volume":"29","author":"Zhang","year":"2022","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2026.114949_bb0190","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1039\/D3TB02393A","article-title":"\u0392-glycosidase sensitive oral nanoparticles for combined photothermal and chemo treatment of colorectal cancer","volume":"12","author":"Jingning","year":"2024","journal-title":"J. Mater. Chem. B Mater. Biol. Med."},{"key":"10.1016\/j.jconrel.2026.114949_bb0195","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jconrel.2021.04.035","article-title":"Alendronate-functionalized hypoxia-responsive polymeric micelles for targeted therapy of bone metastatic prostate cancer","volume":"334","author":"Mengmeng","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114949_bb0200","first-page":"2167","article-title":"Hypoxia-responsive polypeptide nanoparticles loaded with doxorubicin for breast cancer therapy","volume":"6","author":"Peng","year":"2021","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.jconrel.2026.114949_bb0205","article-title":"Bioresponsive immunotherapeutic materials","volume":"36","author":"Han","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.114949_bb0210","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/s41401-020-0372-z","article-title":"Advanced biomaterials for cancer immunotherapy","volume":"41","author":"Fan","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.jconrel.2026.114949_bb0215","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41573-018-0006-z","article-title":"Delivery technologies for cancer immunotherapy","volume":"18","author":"Riley","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.114949_bb0220","article-title":"Polysaccharide-based stimulus-responsive nanomedicines for combination cancer immunotherapy","volume":"19","author":"Qiuxia","year":"2023","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2026.114949_bb0225","article-title":"Tumor microenvironment-responsive nanomedicines for potentiating cancer immunotherapy","volume":"12","author":"Qianqian","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2026.114949_bb0230","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41571-025-01000-6","article-title":"Enhancing immunotherapy with tumour-responsive nanomaterials","volume":"22","author":"Linderman","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2026.114949_bb0235","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12943-025-02357-z","article-title":"Precision nanomedicine: navigating the tumor microenvironment for enhanced cancer immunotherapy and targeted drug delivery","volume":"24","author":"Sabit","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2026.114949_bb0240","first-page":"272","article-title":"Nanomaterials targeting tumor associated macrophages for cancer immunotherapy","volume":"341","author":"Caiyan","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114949_bb0245","doi-asserted-by":"crossref","first-page":"17332","DOI":"10.1002\/anie.202002780","article-title":"Improving cancer immunotherapy outcomes using biomaterials","volume":"59","author":"Shuangqian","year":"2020","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2026.114949_bb0250","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2026.114949_bb0255","article-title":"STING-activating polymers boost lymphatic delivery of mRNA vaccine to potentiate cancer immunotherapy","volume":"37","author":"Zhang","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.114949_bb0260","article-title":"Tumor microenvironment-responsive nanoparticles amplifying STING signaling pathway for cancer immunotherapy","volume":"36","author":"Liu","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.114949_bb0265","article-title":"Acid-ionizable iron nanoadjuvant augments STING activation for personalized vaccination immunotherapy of cancer","volume":"35","author":"Chen","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.114949_bb0270","article-title":"Tumor-microenvironment-activatable polymer nano-immunomodulator for precision cancer photoimmunotherapy","volume":"34","author":"Liu","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.114949_bb0275","article-title":"Dynamic size-change nanovaccine for enhancing lymph node deep penetration and eliciting robust antitumor immune responses","volume":"37","author":"Liu","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.114949_bb0280","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41565-025-02071-3","article-title":"Nanorobots hold PD-L1 and break membrane of colorectal cancer cells for immunotherapy","volume":"21","author":"Ying","year":"2025","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.114949_bb0285","doi-asserted-by":"crossref","first-page":"13545","DOI":"10.1021\/jacs.5c00481","article-title":"Dynamic DNA-based nanoadjuvants for TLR9 clustering and innate immune activation in dendritic cells","volume":"147","author":"Lv","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2026.114949_bb0290","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41392-025-02447-w","article-title":"Condensate nanovaccine adjuvants augment CD8+ t-cell-dependent antitumor immunity through mtDNA leakage-triggered cGAS-STING axis activation","volume":"10","author":"Tang","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.114949_bb0295","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1021\/acsnano.3c10037","article-title":"Tumor-microenvironment-activatable nanoparticle mediating immunogene therapy and m2 macrophage-targeted inhibitor for synergistic cancer immunotherapy","volume":"18","author":"Hu","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.114949_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.02.061","article-title":"STING pathway activation with cisplatin polyprodrug nanoparticles for chemo-immunotherapy in ovarian cancer","volume":"381","author":"Fu","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114949_bb0305","doi-asserted-by":"crossref","first-page":"34659","DOI":"10.1021\/jacs.5c09791","article-title":"An activatable and covalent tumor-associated antigen capturer enabling systemic injection in vivo for promoted antitumor immunity","volume":"147","author":"Gao","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2026.114949_bb0310","doi-asserted-by":"crossref","first-page":"5074","DOI":"10.1038\/s41467-025-60448-3","article-title":"Neoantigens combined with in situ cancer vaccination induce personalized immunity and reshape the tumor microenvironment","volume":"16","author":"Feng","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.114949_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114534","article-title":"NQO1-responsive trimethyl lock benzoquinone: a cleavable linker strategy for antibody-drug conjugates","volume":"390","author":"Wang","year":"2026","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114949_bb0320","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202209379","article-title":"A dual-responsive STAT3 inhibitor nanoprodrug combined with oncolytic virus elicits synergistic antitumor immune responses by igniting pyroptosis","volume":"35","author":"Su","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.114949_bb0325","doi-asserted-by":"crossref","first-page":"8586","DOI":"10.1038\/s41467-024-53010-0","article-title":"Polymeric nanocarrier via metabolism regulation mediates immunogenic cell death with spatiotemporal orchestration for cancer immunotherapy","volume":"15","author":"Guo","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.114949_bb0330","first-page":"eadr1728","article-title":"Tumor-targeting nanocarriers amplified immunotherapy of cold tumors by STING activation and inhibiting immune evasion, science","volume":"11","author":"Zhao","year":"2025","journal-title":"Advances"},{"key":"10.1016\/j.jconrel.2026.114949_bb0335","article-title":"AIE-augmented NIR-II-emissive supramolecular metallacycle nanoplatform for tumor microenvironment-responsive chemo-photothermal-immunotherapy","volume":"15","author":"Chen","year":"2025","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2026.114949_bb0340","article-title":"An endoplasmic reticulum stress-specific nanoinducer selectively evokes type-II immunogenic cell death for pyroptotic cancer immunotherapy","volume":"37","author":"Zhang","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.114949_bb0345","doi-asserted-by":"crossref","first-page":"4318","DOI":"10.1038\/s41467-022-32050-4","article-title":"Engineered bioorthogonal POLY-PROTAC nanoparticles for tumour-specific protein degradation and precise cancer therapy","volume":"13","author":"Gao","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.114949_bb0350","article-title":"PH-sensitive, tail-modified, ester-linked ionizable cationic lipids for gene delivery","volume":"139","author":"Yu","year":"2022","journal-title":"Biomater. Adv."},{"key":"10.1016\/j.jconrel.2026.114949_bb0355","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ejpb.2021.04.008","article-title":"A small molecule nanodrug consisting of pH-sensitive ortho ester-dasatinib conjugate for cancer therapy","volume":"163","author":"Jialu","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2026.114949_bb0360","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1039\/D5AY00206K","article-title":"Development of amide-based molecular cages for the highly selective and sensitive detection of nicotine","volume":"17","author":"Mina","year":"2025","journal-title":"Anal. Methods"},{"key":"10.1016\/j.jconrel.2026.114949_bb0365","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.aca.2020.03.050","article-title":"Real-time monitoring of intracellular pH in live cells with fluorescent ionic liquid","volume":"1111","author":"Lifang","year":"2020","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jconrel.2026.114949_bb0370","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1021\/bc060327a","article-title":"An acetal-based PEGylation reagent for pH-sensitive shielding of DNA polyplexes","volume":"18","author":"Veronika","year":"2007","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2026.114949_bb0375","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1021\/bm200956u","article-title":"Oxime linkage: a robust tool for the design of pH-sensitive polymeric drug carriers","volume":"12","author":"Yue","year":"2011","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2026.114949_bb0380","first-page":"5340","article-title":"pH-sensitive nanocarrier assisted delivery of adenosine to treat osteoporotic bone loss, biomaterials","volume":"10","author":"Hunter","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2026.114949_bb0385","doi-asserted-by":"crossref","first-page":"8967","DOI":"10.2147\/IJN.S516434","article-title":"DS-modified paeoniflorin pH-responsive lipid-polymer hybrid nanoparticles for targeted macrophage polarization in a rat model of rheumatoid arthritis","volume":"20","author":"Junhao","year":"2025","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2026.114949_bb0390","article-title":"AND logic nanoparticle for precision immunotherapy of metastatic cancers","author":"Shuyue","year":"2026","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.114949_bb0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2022.101400","article-title":"Bioinspired magnetic nanocomplexes amplifying STING activation of tumor-associated macrophages to potentiate cancer immunotherapy","volume":"43","author":"Li","year":"2022","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2026.114949_bb0400","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ccell.2025.12.013","article-title":"Ubiquitination-directed cytosolic DNA degradation governs cGAS-STING-mediated immune response to DNA damage","volume":"44","author":"Li","year":"2026","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2026.114949_bb0405","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41392-023-01624-z","article-title":"The cGAS-STING pathway-dependent sensing of mitochondrial DNA mediates ocular surface inflammation","volume":"8","author":"Ouyang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.114949_bb0410","doi-asserted-by":"crossref","first-page":"eadj3945","DOI":"10.1126\/sciimmunol.adj3945","article-title":"STING licensing of type I dendritic cells potentiates antitumor immunity","volume":"9","author":"Wang","year":"2024","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.jconrel.2026.114949_bb0415","doi-asserted-by":"crossref","first-page":"7862","DOI":"10.1021\/acs.nanolett.1c03089","article-title":"GSH-responsive nanoprodrug to inhibit glycolysis and alleviate immunosuppression for cancer therapy","volume":"21","author":"Liu","year":"2021","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2026.114949_bb0420","article-title":"A triple-responsive polymeric prodrug nanoplatform with extracellular ROS consumption and intracellular H(2)O(2) self-generation for imaging-guided tumor chemo-ferroptosis-immunotherapy","volume":"13","author":"Li","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2026.114949_bb0425","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.colsurfb.2015.09.017","article-title":"Biocompatibility evaluation of pH and glutathione-responsive nanohydrogels after intravenous administration","volume":"136","author":"P\u00e9rez","year":"2015","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2026.114949_bb0430","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.3390\/cancers17223717","article-title":"PSMA theranostics in prostate cancer and beyond: current and future perspectives","volume":"17","author":"Sandhu","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.jconrel.2026.114949_bb0435","doi-asserted-by":"crossref","first-page":"5861","DOI":"10.1021\/acsabm.4c00819","article-title":"Prostate-specific membrane antigen-targeted NIR phototheranostics for prostate cancer","volume":"7","author":"Krishna","year":"2024","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.jconrel.2026.114949_bb0440","doi-asserted-by":"crossref","first-page":"2415322","DOI":"10.1002\/adma.202415322","article-title":"PSMA-targeted nanoparticles with PI3K\/mTOR dual inhibitor downregulate p-glycoprotein and inactivate myeloid-derived suppressor cells for enhanced chemotherapy and immunotherapy in prostate cancer","volume":"37","author":"Yin","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.114949_bb0445","first-page":"1411","article-title":"Cancer-cell stiffening via cholesterol depletion enhances adoptive t-cell immunotherapy, nature","volume":"5","author":"Lei","year":"2021","journal-title":"Biomed. Eng."},{"key":"10.1016\/j.jconrel.2026.114949_bb0450","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1038\/s41467-025-57718-5","article-title":"Supramolecular polyrotaxane-based nano-theranostics enable cancer-cell stiffening for enhanced t-cell-mediated anticancer immunotherapy","volume":"16","author":"Luo","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.114949_bb0455","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202102668","article-title":"Engineering chameleon prodrug nanovesicles to increase antigen presentation and inhibit PD-L1 expression for circumventing immune resistance of cancer","volume":"33","author":"Zhou","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.114949_bb0460","doi-asserted-by":"crossref","first-page":"6445","DOI":"10.1021\/acsnano.3c11958","article-title":"Cathepsin b-responsive programmed brain targeted delivery system for chemo-immunotherapy combination therapy of glioblastoma","volume":"18","author":"Jiang","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.114949_bb0465","doi-asserted-by":"crossref","first-page":"22412","DOI":"10.1021\/jacs.5c00124","article-title":"Engineering of sono-activatable immunogels for immunometabolism disorder normalization therapy of breast cancer","volume":"147","author":"Guo","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2026.114949_bb0470","doi-asserted-by":"crossref","first-page":"10418","DOI":"10.1038\/s41467-024-54382-z","article-title":"\u0393-Glutamyl transpeptidase-activable nanoprobe crosses the blood-brain barrier for immuno-sonodynamic therapy of glioma","volume":"15","author":"Li","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.114949_bb0475","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1039\/D2BM00067A","article-title":"Enzyme-responsive strategy as a prospective cue to construct intelligent biomaterials for disease diagnosis and therapy","volume":"10","author":"Meiyu","year":"2022","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2026.114949_bb0480","doi-asserted-by":"crossref","first-page":"5554","DOI":"10.1039\/C7CS00663B","article-title":"Development of endogenous enzyme-responsive nanomaterials for theranostics","volume":"47","author":"Jing","year":"2018","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2026.114949_bb0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123545","article-title":"Enzyme-responsive biomimetic ferritin nanoparticles for selective cancer therapy","volume":"325","author":"Hao","year":"2026","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2026.114949_bb0490","doi-asserted-by":"crossref","first-page":"39547","DOI":"10.1021\/jacs.5c12835","article-title":"Self-assembly of artificial topological nanostructures for enhanced bioorthogonal activation and drug penetration for cancer immunotherapy","volume":"147","author":"Dong","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2026.114949_bb0495","doi-asserted-by":"crossref","first-page":"5216","DOI":"10.1038\/s41467-023-40996-2","article-title":"A photo-triggered self-accelerated nanoplatform for multifunctional image-guided combination cancer immunotherapy","volume":"14","author":"Xiaoying","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.114949_bb0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120847","article-title":"Tumor hypoxia-activated combinatorial nanomedicine triggers systemic antitumor immunity to effectively eradicate advanced breast cancer","volume":"273","author":"Liu","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2026.114949_bb0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2026.124083","article-title":"Hypoxia-responsive paclitaxel prodrugs: linker evaluation and NIR-triggered self-amplifying photodynamic-chemotherapy nanoplatform","volume":"330","author":"Lv","year":"2026","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2026.114949_bb0510","doi-asserted-by":"crossref","first-page":"6193","DOI":"10.1021\/acsnano.2c07488","article-title":"Identifying TOPK and hypoxia hallmarks in esophageal tumors for photodynamic\/chemo\/immunotherapy and liver metastasis inhibition with nanocarriers","volume":"17","author":"Shi","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.114949_bb0515","article-title":"Azide-masked resiquimod activated by hypoxia for selective tumor therapy","volume":"35","author":"Sun","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.114949_bb0520","doi-asserted-by":"crossref","first-page":"10395","DOI":"10.1038\/s41467-024-53906-x","article-title":"A hypoxia-activated and microenvironment-remodeling nanoplatform for multifunctional imaging and potentiated immunotherapy of cancer","volume":"15","author":"Song","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.114949_bb0525","doi-asserted-by":"crossref","first-page":"13526","DOI":"10.1021\/acsnano.1c04263","article-title":"Nanoprobe-based magnetic resonance imaging of hypoxia predicts responses to radiotherapy, immunotherapy, and sensitizing treatments in pancreatic tumors","volume":"15","author":"Liu","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.114949_bb0530","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202202063","article-title":"Smart nanoparticle-based platforms for regulating tumor microenvironment and cancer immunotherapy","volume":"12","author":"Cheng","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2026.114949_bb0535","article-title":"Sequentially activated smart DNA nanospheres for photoimmunotherapy and immune checkpoint blockade","volume":"12","author":"Chen","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2026.114949_bb0540","article-title":"A logic-gated trispecific engager enhances macrophage killing of cancer cells in solid tumors","volume":"13","author":"Xiaotian","year":"2026","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.114949_bb0545","article-title":"Split-deliver-click: tumor-specific protein degradation via \u201cAND\u201d logic-gated in-cell bioorthogonal clicking of PROTACs","volume":"65","author":"He","year":"2026","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2026.114949_bb0550","article-title":"A general logic-gating framework for CAR-T and nanocarrier cancer therapies: a cross-platform comparative analysis of logic architectures and their molecular implementation strategies","volume":"391","author":"Patrick","year":"2026","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114949_bb0555","doi-asserted-by":"crossref","first-page":"8058","DOI":"10.1021\/acsnano.4c16194","article-title":"Logic-gated modulation of cell migration via mesoscale mechanical uncaging effects","volume":"19","author":"Deepak","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.114949_bb0560","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.apsb.2023.09.016","article-title":"Logic-gated tumor-microenvironment nanoamplifier enables targeted delivery of CRISPR\/Cas9 for multimodal cancer therapy","volume":"14","author":"Yongchun","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2026.114949_bb0565","doi-asserted-by":"crossref","first-page":"6468","DOI":"10.1021\/acsnano.4c17285","article-title":"A dual stimuli-responsive nanoimmunomodulator for antitumor synergy of macrophages and t cells","volume":"19","author":"Ding","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.114949_bb0570","article-title":"De novo design of structure-tunable multivalent targeting chimeras for tumor-targeted PD-L1 degradation and potentiated cancer immunotherapy","volume":"64","author":"Zhou","year":"2025","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2026.114949_bb0575","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1384","article-title":"MRNA vaccine in cancer therapy: current advance and future outlook","volume":"13","author":"Li","year":"2023","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.jconrel.2026.114949_bb0580","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12943-021-01335-5","article-title":"MRNA vaccine for cancer immunotherapy","volume":"20","author":"Lei","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2026.114949_bb0585","first-page":"42221","article-title":"Ultrasound-activatable lipid nanoplatform for region-confined innate immune stimulation and mRNA vaccination therapy of cancer","volume":"147","author":"Chen","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2026.114949_bb0590","doi-asserted-by":"crossref","DOI":"10.1038\/s41551-025-01577-4","article-title":"Low reactogenicity and high tumour antigen expression from mRNA-LNPs with membrane-destabilizing zwitterionic lipids","author":"Zhao","year":"2025","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2026.114949_bb0595","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2026.115821","article-title":"NanoTAC in targeted protein degradation: intelligent delivery platforms and synergistic therapeutic paradigms","volume":"232","author":"Qian","year":"2026","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.114949_bb0600","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.1038\/s41467-025-60107-7","article-title":"Linker-free PROTACs efficiently induce the degradation of oncoproteins","volume":"16","author":"Jianchao","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.114949_bb0605","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.tips.2024.10.006","article-title":"Development of PROTACs using computational approaches","volume":"45","author":"Jingxuan","year":"2024","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jconrel.2026.114949_bb0610","doi-asserted-by":"crossref","first-page":"5498","DOI":"10.1039\/D2CS00197G","article-title":"Chasing molecular glue degraders: screening approaches","volume":"51","author":"Domostegui","year":"2022","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2026.114949_bb0615","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41392-024-01983-1","article-title":"Sequential responsive nano-PROTACs for precise intracellular delivery and enhanced degradation efficacy in colorectal cancer therapy","volume":"9","author":"Yang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.114949_bb0620","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/s41586-025-09903-1","article-title":"Intratumoural vaccination via checkpoint degradation-coupled antigen presentation","volume":"650","author":"Han","year":"2026","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.114949_bb0625","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2026.218353","article-title":"YTHDF1-mediated RNA m1A methylation promotes malignant progression of hepatocellular carcinoma via regulating LRP5\/Wnt-\u03b2-catenin axis","volume":"645","author":"Gu","year":"2026","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2026.114949_bb0630","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1136\/gutjnl-2022-328845","article-title":"Targeting m(6)A reader YTHDF1 augments antitumour immunity and boosts anti-PD-1 efficacy in colorectal cancer","volume":"72","author":"Bao","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.jconrel.2026.114949_bb0635","doi-asserted-by":"crossref","first-page":"7340","DOI":"10.1038\/s41467-025-61974-w","article-title":"Epigenetic modulation with nanosatellite triggers tumoricidal immunity for hepatocellular carcinoma treatment","volume":"16","author":"Qu","year":"2025","journal-title":"Nat. Commun."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926003524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926003524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T11:26:07Z","timestamp":1783077967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926003524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":127,"alternative-id":["S0168365926003524"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114949","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor microenvironment activatable immunomodulator for cancer immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114949","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114949"}}